Investor desk
Investors should track partnership announcements and pipeline signals from Phacilitate Advanced Therapies.
← Back to Events
Tier 1 Global Networking: High MANUFACTURING CONCLUDED
Phacilitate Advanced Therapies — 2026 — Convention Center San Diego, San Diego, USA
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem.
Presentation data updated May 4, 2026, 9:00 AM UTC
Why This Event Matters
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem.
Industry impact
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem..
Market implications
Expect signals on pricing, formulary strategy, and partnership economics in US markets.
Regulatory implications
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Investor implications
Investors should track partnership announcements and pipeline signals from Phacilitate Advanced Therapies.
Competitive implications
Competitive positioning among manufacturing players is a core theme — compare with prior editions.
Event Significance
Tier-1 industry catalyst
30 /100 composite
Phacilitate Advanced Therapies is a targeted manufacturing forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
- Speaker quality 14/20
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
- Company participation 0/20
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
- Historical influence 10/20
Some historical catalysts; compare readouts against last cycle.
- Media coverage 6/20
Niche coverage — subscribe for direct abstract alerts.
- Pipeline relevance 0/20
Early science or services-focused — lower near-term PDUFA linkage.
Key Takeaways
Key Themes
manufacturingPhacilitatePipeline announcements
Key Markets
US Americas
Key Opportunities
Partnership dealsLicensing discussionsVendor selection
Timeline & Milestones
- Pre-event intelligence Complete
Abstract discovery in progress; monitor Key Data tab.
- Conference opens Feb 9, 2026 Complete
Live readouts, late-breakers, and partnership announcements.
- Live coverage window Complete
Nova editorial monitors confirmed data releases.
- Conference closes Feb 12, 2026 Complete
Post-event recap, competitive takeaways, and trial updates.
BD teams Investors & analysts Regulatory leaders
Executive Summary
C-level briefNow in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem.
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Analyst Watch
Regulatory affairs
FDA and CMS policy on evidence generation and real-world data often surface at leadership forums.
Competitive intelligence
Competitive positioning among manufacturing players is a core theme — compare with prior editions.
vs. Prior Editions
| Edition | Presentations | Companies |
|---|---|---|
| Phacilitate Advanced Therapies (current) | 0 | 0 |
| Advanced Therapies Week (2026) | 0 | 0 |
Competitive Landscape
Company map →Competitive positioning among manufacturing players is a core theme — compare with prior editions.
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
Related News & Research
Research hub →Event Intelligence Summary
Standalone summaries for Phacilitate Advanced Therapies — optimized for research and AI retrieval.
Executive Summary
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem.
Analyst View
Now in its 21st year, Advanced Therapies Week is the premier biotech partnering event in the United States, bringing together leaders in research, therapeutic development, and advanced manufacturing in the cell and gene therapy ecosystem..
Investor View
Investors should track partnership announcements and pipeline signals from Phacilitate Advanced Therapies.
BD View
BD teams should prioritize partnership and licensing conversations at Phacilitate Advanced Therapies.
Key Facts
- Event
- Phacilitate Advanced Therapies
- Focus
- manufacturing
- Region
- US Americas
- Location
- San Diego, USA
Ask Nova AI
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
Frequently Asked Questions
What is Phacilitate Advanced Therapies?
Phacilitate Advanced Therapies is a manufacturing industry conference for executives, clinical leaders, and investors.
Who attends Phacilitate Advanced Therapies?
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on manufacturing.
Why is Phacilitate Advanced Therapies important?
Phacilitate Advanced Therapies influences partnership timing and policy debates affecting manufacturing markets for the next 12–18 months.
Where is Phacilitate Advanced Therapies held?
Phacilitate Advanced Therapies is held in San Diego, USA.
What should investors watch at Phacilitate Advanced Therapies?
Track partnership announcements, pipeline readouts, and management commentary on manufacturing catalysts.
What BD opportunities exist at Phacilitate Advanced Therapies?
BD teams use Phacilitate Advanced Therapies for licensing, co-development, and vendor selection across manufacturing.
How does Phacilitate Advanced Therapies compare with other pharma conferences?
Phacilitate Advanced Therapies is a tier-1 global congress for manufacturing — compare with peer events in the same vertical.
How do I get NovaPharmaNews coverage of Phacilitate Advanced Therapies?
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.